Jcr Pharmaceuticals Co., Ltd. (4552) Press Release
Matters Concerning Controlling Shareholders (Affiliated Companies)
Earlier from Jcr Pharmaceuticals
- JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform
- JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders
- JCR Pharmaceuticals: FY2025 Third Quarter Results Briefing Session - Script（1,742KB）
- JCR Pharmaceuticals: FY2025-Q3 Financial Report (Oct. 1-Dec. 31, 2025)（390KB）